Join us at Fin|Tech|Bio at Canary Wharf, returning to Level39 in partnership with Canary Wharf Group Life Sciences, for a highly anticipated evening exploring the future at the intersection of finance, technology, life sciences, and healthcare.

Expect engaging discussions on how data is transforming industries—from enabling personalised medicine to powering precision finance and discover how collaboration, governance, and emerging technologies are unlocking new opportunities.

Fin|Tech|Bio details

Time: 5:30pm – 8:00pm
Date: Tuesday, 24th February 2026
Organisers: Level39 & Canary Wharf Group Life Sciences
Venue: Level39, One Canada Square, Canary Wharf, London

Agenda:

5:30pm – 6:10pm: Arrival & Networking

6:10pm – 6:15pm: Welcome & Opening Remarks – Level39 & Canary Wharf Group

6:15pm – 6:25pm: CPRD Emulate Showcase – Mike McMillan, Business Development Team Leader, CPRD

6:25pm – 7:15pm: Panel Discussion & Audience Q&A with:

• Catriona Campbell – Author, Speaker, Chair, AI 100, UK
• Michael Cook – Chief Science Officer, Our Future Health UK
• Adi Ben-Ari – Founder & CEO, Applied Blockchain
• John Baker – CEO, IMU Biosciences

7:15pm – 8:00pm: Closing Remarks & Networking

About the Speakers

This panel brings together leaders with expertise spanning health data, AI, blockchain, digital transformation, and precision medicine:

Mike McMillan, CPRD
Driving partnerships, products, and services focused on data, AI, and digital solutions for healthcare research and regulation.

Catriona Campbell, AI 100, UK
Author, technologist, and Chair of the Scottish AI Alliance, with 20+ years in digital transformation and responsible AI.

Michael Cook, Our Future Health UK
AI-driven immune profiling for precision medicine, with scientific and commercial leadership from Abcam and Bain & Company.

Adi Ben-Ari, Applied Blockchain
Recognised blockchain and cryptography thought leader, government advisor, and co-inventor of multiple data privacy patents.

John Baker, IMU Biosciences
Leading AI-driven precision medicine initiatives with senior biotech and scientific leadership experience.

About Fin|Tech|Bio at Canary Wharf

Fin|Tech|Bio brings together leaders from finance, technology, and life sciences to explore cross-sector data ecosystems and their role in creating value, accelerating breakthroughs, and improving outcomes.

The evening will feature:

• Opening remarks from Level39 and Canary Wharf Group
• Panel discussion & Q&A with experts in FinTech, Health, and Life Sciences
• Networking with founders, operators, investors, and ecosystem leaders

Key topics include:

• Data as a catalyst: Unlocking innovation through shared ecosystems
• Cross-sector synergies: Collaborations across finance, healthcare, and life sciences
• Governance & compliance: Navigating regulation, ethics, and trust
• Emerging technologies: AI, blockchain, and secure data platforms

Key takeaways from Fin|Tech|Bio

Attendees will:

• Explore real-world applications of cross-sector data collaboration
• Gain insight into responsible and ethical data use
• Learn how emerging technologies enable secure, trusted partnerships
• Connect with industry leaders and innovators